Wells Fargo & Company Amphastar Pharmaceuticals, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 71,786 shares of AMPH stock, worth $3.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,786
Previous 57,241
25.41%
Holding current value
$3.49 Million
Previous $2.51 Million
14.25%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$289 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$130 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$94.6 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$82.3 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$78.9 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.38B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...